WISCONSIN HUMAN PROTEOMICS SYMPOSIUM

EVENT POSTER

PROGRAM

The Human Proteomics Program (HPP)at the University of Wisconsin-Madison and the BioPharmaceutical Technology Center Institute (BTC Institute) were pleased to offer this excellent program. It included 20 invited oral presentations from nationally recognized researchers in modern mass spectrometry/proteomics with an emphasis on how these technologies will impact human health.

Speakers addressed a range of proteomics applications in basic and clinical biomedical research, instrumentation/technique development and potential applications in clinical practice. All talks were presented in a plenary format. Attendees heard about cutting-edge proteomics technology developments and proteomics applications in cardiovascular diseases, cancer and neurodegenerative diseases.

Attendees were also invited to present their recent work in scientific poster sessions.

PRESENTERS

HONORARY SYMPOSIUM CHAIR

Richard Moss, Ph.D.
Professor, Department of Cell and Regenerative Biology
Senior Associate Dean for Basic Research, Biotechnology and Graduate Studies
Executive Director, Master of Science in Biotechnology
Director, UW Cardiovascular Research Center
School of Medicine and Public Health, University of Wisconsin-Madison

KEYNOTE SPEAKER

Richard D. Smith, Ph.D.
Battelle Fellow and Chief Scientist
Environmental Molecular Sciences Laboratory and Biological Sciences Division
Pacific Northwest National Laboratory

SESSION CHAIRS

SESSION 1: Proteomics Technologies
Michael R. Sussman, Ph.D.
Professor, Department of Biochemistry
Director, UW Biotechnology Center
University of Wisconsin-Madison

SESSION 2: Proteomics Applications in Cardiovascular Diseases
Marion Greaser, Ph.D.
Professor, Department of Animal Sciences
Director of the Muscle Biology Laboratory
University of Wisconsin-Madison

SESSION 3: Proteomics Application in Neurodegenerative Disease
Martha M. Vestling, Ph.D.
Director of the Mass Spectrometry Facility
Department of Chemistry
University of Wisconsin-Madison

SESSION 4: Proteomics Application in Cancer
William F. Dove, Ph.D.
George Streisinger Professor of Experimental Biology
Professor of Oncology and Medical Genetics
McArdle Laboratory for Cancer Research
School of Medicine and Public Health, University of Wisconsin-Madison

John M. Denu, Ph.D.
Epigenetics Theme Leader, Wisconsin Institute for Discovery
Professor, Biomolecular Chemistry
School of Medicine and Public Health, University of Wisconsin

SPEAKERS

  • Joshua Coon, Ph.D.
    Associate Professor, Departments of Chemistry and Bimolecular Chemistry
    University of Wisconsin-Madison
  • Catherine E. Costello, Ph.D.
    Professor, Departments of Biochemistry and Biophysics
    Director, Mass Spectrometry Resource
    Director, Cardiovascular Proteomics Center
    Boston University School of Medicine
  • Ying Ge, Ph.D.
    Director of Mass Spectrometry, Human Proteomics Program
    School of Medicine and Public Health, University of Wisconsin-Madison
  • David R. Goodlett, Ph.D.
    Professor, Medicinal Chemistry
    University of Washington
  • Michael L. Gross, Ph.D.
    Professor, Department of Chemistry
    Professor of Immunology and Internal Medicine
    Director and Principal Investigator, Mass Spectrometry Resource
    Washington University
  • Kristina Hakansson, Ph.D.
    Associate Professor of Chemistry
    University of Michigan
  • Sam Hanash, M.D., Ph.D.
    Program Head and Full Member, Molecular Diagnostics
    Public Health Sciences
    Fred Hutchinson Cancer Research Center
  • Lan Huang, Ph.D.
    Associate Professor, Developmental & Cell Biology, School of Biological Sciences
    Associate Professor, Physiology & Biophysics, School of Medicine
    University of California, Irvine
  • Neil Kelleher, Ph.D.
    Professor of Molecular Biosciences, Department of Molecular Biosciences, Weinberg College of Arts and Sciences; Director, Proteomics Center of Excellence
    Northwestern University
  • Carlito B. Lebrilla, Ph.D.
    Professor, Department of Chemistry
    University of California, Davis
  • Lingjun Li, Ph.D.
    Associate Professor, School of Pharmacy and Department of Chemistry
    University of Wisconsin-Madison
  • David C. Muddiman, Ph.D.
    Professor, Mass Spectrometry
    Department of Chemistry
    North Carolina State University
  • Peipei Ping, Ph.D., FISHR, FAHA
    Professor and Director
    NHLBI Proteomics Center at UCLA
    NHLBI PPG on Myocardial Ischemic Injury
    School of Medicine, University of California, Los Angeles
  • Lloyd M. Smith, Ph.D.
    Professor, Department of Chemistry
    University of Wisconsin-Madison
  • Judith A. J. Steen, Ph.D.
    Assistant Professor of Neurology
    Harvard Medical School;
    Associate in Neurology
    F.M. Kirby Neurobiology Center, Children's Hospital Boston
  • Antony O. W. Stretton, Ph.D.
    Professor, Zoology Department and Neuroscience Training Program
    University of Wisconsin-Madison
  • Jennifer Van Eyk, Ph.D.
    Director and Center Investigator, The Johns Hopkins NHLBI Proteomics Center; Director, Bayview Proteomics Center; Professor of Medicine, Division of Cardiology, Biological Chemistry and Biomedical Engineering
    Johns Hopkins School of Medicine
  • Yinsheng Wang, Ph.D.
    Professor in Chemistry; Director, Environmental Toxicology Graduate Program
    University of California at Riverside
  • Yingming Zhao, Ph.D.
    Associate Professor, The Ben May Department for Cancer Research
    University of Chicago
ABSTRACTS

SCHEDULE

This Symposium was designed to build upon a very successful event offered by HPP in 2007. Beginning with an opportunity to visit open houses at UW-Madison facilities and attend an opening reception at the Pyle Center on Thursday afternoon, August 4, the event continued with two days of talks, panel discussions, poster sessions, and sponsor exhibits at the BioPharmaceutical Technology Center (BTC) Friday and Saturday, August 5-6, 2011. There were many opportunities for discussion and intermingling. SCHEDULE

POSTER SESSION

Meeting attendees were encouraged to submit posters on novel research projects relevant to the Symposium theme. Posters addressed research questions rather than product descriptions or usage. Posters were accepted on a first come basis and screened for appropriateness by the Symposium Organizing Committee. Thirty-three posters were presented.

SYMPOSIUM ORGANIZING COMMITTEE:

  • Ying Ge, Ph.D.
    Director of Mass Spectrometry, Human Proteomics Program
    School of Medicine and Public Health, University of Wisconsin-Madison
  • Lingjun Li, Ph.D.
    Associate Professor of Pharmaceutical Sciences and Chemistry, University of Wisconsin-Madison
  • Martha Vestling, Ph.D.
    Director, Mass Spectrometry Facility
    Department of Chemistry, UW-Madison
  • Amy Prevost, M.S.
    Director of Scientific Courses
    BioPharmaceutical Technology Center Institute
  • Karin Borgh, Ph.D.
    Executive Director
    BioPharmaceutical Technology Center Institute